Addressing Life Long Needs in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy is the most common fatal genetic disorder diagnosed in childhood, affecting approximately 1 in every 4600 live male births (about 20,000 new cases each year worldwide). Because the Duchenne gene is found on the X-chromosome, it primarily affects boys; however, girls may be effected and it occurs across all races and cultures. Duchenne results in progressive loss of strength and is caused by a mutation in the gene that encodes for dystrophin. Because dystrophin is absent, the muscle cells are easily damaged. The progressive muscle weakness leads to serious medical problems, particularly issues relating to the heart and lungs. Young men with Duchenne typically live into their late twenties.
Learning Objectives
- Describe etiology, pathology, pathokinesiology, and signs/symptoms, including differential diagnosis of Duchenne
- Discuss common medications and supplements seen in this population
- Discuss current understanding of Duchenne based on longitudinal research studies
- Discuss and describe identified biomarkers in Duchenne related to current research outcomes
- Discuss, describe, justify, and determine role of PT in assessment, intervention, and care across the ICF and across the lifespan: including selection of appropriate therapy goals, exercises, stretching, and optimizing function across multiple age ranges
- Determine and justify equipment needs including orthotic intervention across multiple age ranges, and will be able to discuss clinical problem solving and decision making regarding equipment and orthotic intervention in a variety of contexts.
Available Credit
- 8.00 ANCC
- 8.00 JA Credit - AH

Facebook
X
LinkedIn
Forward